JP
Publications
48
Views
19,769
Downloads
2,807
Supervised works
0
Items per page
1 - 48 of 48
Title Published in Access level OA Policy Year Views Downloads
Recommandations pour la prévention, le diagnostic et la thérapie des addictions à l’âge avancéRevue médicale suisse
accessLevelPublic
2022 31 41
Plasma Proteomic Biomarkers Relating to Alzheimer's Disease: A Meta-Analysis Based on Our Own StudiesFrontiers in aging neuroscience
accessLevelPublic
2021 72 61
Relationship between delirium and depression in old ageSwiss archives of neurology, psychiatry and psychotherapy
accessLevelPublic
2021 267 119
Empfehlungen für die Prävention, Diagnostik und Therapie der Abhängigkeitserkrankungen im AlterPraxis
accessLevelRestricted
2021 14 0
Replication study of plasma proteins relating to Alzheimer's pathologyAlzheimer's & dementia
accessLevelPublic
2021 179 63
A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohortAlzheimer's & dementia
accessLevelPublic
2019 449 178
Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assayAlzheimer's & Dementia
accessLevelPublic
2019 296 216
Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohortAlzheimer's & Dementia
accessLevelPublic
2019 289 184
Preoperative Depression and Plasma Cortisol Levels as Predictors of Delirium after Cardiac SurgeryDementia and geriatric cognitive disorders
accessLevelPrivate
2019 164 0
The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristicsAlzheimer's Research and Therapy
accessLevelRestricted
2018 470 0
Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's diseaseAlzheimer's & Dementia
accessLevelRestricted
2018 400 3
Do diurnal cortisol levels mediate the association between sleep disturbances and cognitive impairment?Neurobiology of Aging
accessLevelRestricted
2018 426 0
MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery studyAlzheimer's Research and Therapy
accessLevelPublic
2018 450 220
Recommendations of Swiss Memory Clinics for the Diagnosis of DementiaPraxis (Bern 1994)
accessLevelRestricted
2018 528 0
A global HILIC-MS approach to measure polar human cerebrospinal fluid metabolome: Exploring gender-associated variation in a cohort of elderly cognitively healthy subjectsAnalytica Chimica Acta
accessLevelRestricted
2018 439 1
Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without DementiaJAMA Psychiatry
accessLevelPublic
2018 510 349
The Effects of Hand Massage on Stress and Agitation Among People with Dementia in a Hospital Setting: A Pilot StudyApplied Psychophysiology and Biofeedback
accessLevelPublic
2018 447 218
Non-Phosphorylated Tau as a Potential Biomarker of Alzheimer's Disease: Analytical and Diagnostic CharacterizationJournal of Alzheimer's Disease
accessLevelRestricted
2017 763 0
Neuroticism, depression, and anxiety traits exacerbate the state of cognitive impairment and hippocampal vulnerability to Alzheimer's diseaseAlzheimer's & Dementia
accessLevelRestricted
2017 393 0
Personality, Cortisol, and Cognition in Non-demented Elderly Subjects: Results from a Population-Based StudyFrontiers in Aging Neuroscience
accessLevelPublic
2017 399 204
Macrophage Migration Inhibitory Factor is Associated with Biomarkers of Alzheimer's Disease Pathology and Predicts Cognitive Decline in Mild Cognitive Impairment and Mild DementiaJournal of Alzheimer's Disease
accessLevelRestricted
2017 446 0
ICP-MS/MS-Based Ionomics: A Validated Methodology to Investigate the Biological Variability of the Human IonomeJournal of Proteome Research
accessLevelRestricted
2017 406 1
Plasma Proteomic Profiles of Cerebrospinal Fluid-Defined Alzheimer's Disease Pathology in Older AdultsJournal of Alzheimer's Disease
accessLevelRestricted
2017 423 0
Relations between personality changes and cerebrospinal fluid biomarkers of Alzheimer's disease pathologyJournal of Psychiatric Research
accessLevelRestricted
2017 758 1
Life events, salivary cortisol, and cognitive performance in nondemented subjects: a population-based studyNeurobiology of Aging
accessLevelRestricted
2017 421 2
One-carbon metabolism, cognitive impairment and CSF measures of Alzheimer pathology: homocysteine and beyondAlzheimer's Research and Therapy
accessLevelPublic
2017 514 197
Decreasing body mass index is associated with cerebrospinal fluid markers of Alzheimer's pathology in MCI and mild dementiaExperimental Gerontology
accessLevelRestricted
2017 397 0
Sleep characteristics and cognitive impairment in the general population: The HypnoLaus studyNeurology
accessLevelRestricted
2017 1,046 1
Markers of neuroinflammation associated with Alzheimer's disease pathology in older adultsBrain, Behavior and Immunity
accessLevelRestricted
2017 439 0
Interaction between personality traits and cerebrospinal fluid biomarkers of Alzheimer's disease pathology modulates cognitive performanceAlzheimer's Research and Therapy
accessLevelPublic
2017 416 173
Response to a letter to the editor: sleep disturbance as a stressor event in elderly's lifeNeurobiology of Aging
accessLevelRestricted
2017 387 0
L'agitation chez les personnes atteintes de démence : examen de la portée des connaissances et mise en perspective du phénomène selon la théorie du confort et le concept de l'attachementRecherche en soins infirmiers
accessLevelRestricted
2016 527 0
Les biomarqueurs du liquide céphalorachidien dans la maladie d'Alzheimer en pratique clinique couranteRevue médicale suisse
accessLevelPublic
2016 448 229
Recommandations for prevention, diagnostic and therapy of delirium in the elderlyPraxis (Bern 1994)
2016 400 0
Homocysteine metabolism is associated with cerebrospinal fluid levels of soluble amyloid precursor protein and amyloid betaJournal of Neurochemistry
accessLevelRestricted
2016 424 0
Behavioral and psychological symptoms and cognitive decline in patients with amnestic MCI and mild AD: a two-year follow-up studyInternational Psychogeriatrics
accessLevelRestricted
2015 414 0
Delirium in the elderly: Current problems with increasing geriatric ageIndian Journal of Medical Research
accessLevelPublic
2015 401 341
CSF biomarkers for the differential diagnosis of Alzheimer's disease: A large-scale international multicenter studyAlzheimer's and Dementia
accessLevelRestricted
2015 396 0
Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer's typeNeurobiology of Aging
accessLevelRestricted
2015 409 0
Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysisJAMA
accessLevelRestricted
2015 581 2
Empfehlungen zur Diagnostik und Therapie der behavioralen und psychologischen Symptome der Demenz (BPSD)Praxis (Bern 1994)
2014 542 0
Subjective cognitive decline in patients with mild cognitive impairment and healthy older adults: association with personality traitsGeriatrics and Gerontology International
accessLevelRestricted
2014 367 2
SUCLG2 identified as both a determinator of CSF Aβ1-42 levels and an attenuator of cognitive decline in Alzheimer's diseaseHuman Molecular Genetics
accessLevelRestricted
2014 368 1
Predisposing and precipitating factors of delirium after cardiac surgery: a prospective observational cohort studyAnnals of Surgery
accessLevelRestricted
2013 393 0
The evolution of personality in patients with mild cognitive impairmentDementia and Geriatric Cognitive Disorders
accessLevelRestricted
2013 399 0
Delirium and cognitive decline: more than a coincidenceCurrent Opinion in Neurology
accessLevelRestricted
2013 322 0
Cerebral and extracerebral cholesterol metabolism and CSF markers of Alzheimer's diseaseBiochemical Pharmacology
accessLevelRestricted
2013 410 0
Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trialThe Lancet Neurology
accessLevelRestricted
2013 329 0
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack